Anti-NGF-antibody administration as collyrium reduces the presence of NGF and enhances the expression of VEGF in the retina, lacrimal gland and hippocampus

Neuroscience Letters

Volumn 463, Issue 3, 2009, Pages 203-206

  Colafrancesco, Valeria ^a   Cirulli, Francesca ^b   Rossi, Simona ^c   Berry, Alessandra ^b   Aloe, Luigi ^c  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CNR   (Italy)

Author keywords

Choline acetyltransferase; Hippocampus; Lacrimal gland; Nerve growth factor; Retina; Vascular endothelial growth factor

Indexed keywords

CHOLINE ACETYLTRANSFERASE; IMMUNOGLOBULIN G; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; VASCULOTROPIN;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BRAIN CELL; BRAIN NERVE CELL; CELL DEGENERATION; CELL REGENERATION; CONTROLLED STUDY; FEMALE; FOREBRAIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LACRIMAL GLAND; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RETINA;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBODIES; FEMALE; HIPPOCAMPUS; LACRIMAL APPARATUS; MICE; NERVE GROWTH FACTOR; OPHTHALMIC SOLUTIONS; RETINA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 68949198704     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.082     Document Type: Article

References (27)

1. In: Aloe L., and Calzà L. (Eds). NGF and Related Molecules in Health and Disease vol. 146 (2004), Elsevier, Amsterdam 544
2. Ambati J., Canakis C.S., Miller J.W., Gragoudas E.S., Edwards A., Weissgold D.J., Kim I., Delori F.C., and Adamis A.P. Diffusion of high molecular weight compounds through sclera. Invest. Ophthalmol. Vis. Sci. 41 (2000) 1181-1185
3. Amico-Roxas M., Caruso A., Leone M.G., Scifo R., Vanella A., and Scapagnini U. Nerve growth factor inhibits some acute experimental inflammations. Arch. Int. Pharmacodyn. Ther. 299 (1989) 269-285
4. Banks B.E., Vernon C.A., and Warner J.A. Nerve growth factor has anti-inflammatory activity in the rat hindpaw oedema test. Neurosci. Lett. 47 (1984) 41-45
5. Bocchini V., and Angeletti P.U. The nerve growth factor: purification as a 30,000-molecular-weight protein. Proc. Natl. Acad. Sci. U.S.A. 64 (1969) 787-794
6. Braun A., Appel E., Baruch R., Herz U., Botchkarev V., Paus R., Brodie C., and Renz H. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur. J. Immunol. 28 (1998) 3240-3251
7. Chen X.Q., Fawcett J.R., Rahman Y.E., Ala T.A., and Frey I.W. Delivery of nerve growth factor to the brain via the olfactory pathway. J. Alzheimers Dis. 1 (1998) 35-44
8. F. Cirulli, L. Aloe, V. Colafrancesco, F. Sornelli, L.T. Bonsignore, F. Capone, A. Berry, Conjunctivally administered NGF antibody reduces pain sensitivity and anxiety-like behavioral responses in aged mice, submitted for publication.
9. Di Fausto V., Fiore M., Tirassa P., Lambiase A., and Aloe L. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur. J. Neurosci. 26 (2007) 2473-2480
10. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18 (1997) 4-25
11. Flugel A., Matsumuro K., Neumann H., Klinkert W.E., Birnbacher R., Lassmann H., Otten U., and Wekerle H. Anti-inflammatory activity of nerve growth factor in experimental autoimmune encephalomyelitis: inhibition of monocyte transendothelial migration. Eur. J. Immunol. 31 (2001) 11-22
12. Graiani G., Emanueli C., Desortes E., Van Linthout S., Pinna A., Figueroa C.D., Manni L., and Madeddu P. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice. Diabetologia 47 (2004) 1047-1054
13. Koevary S.B. Pharmacokinetics of topical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr. Drug Metab. 4 (2003) 213-222
14. Koevary S.B., Lam V., Patsiopoulos G., and Lake S. Accumulation of porcine insulin in the rat brain and cerebrospinal fluid following ocular application. J. Ocul. Pharmacol. Ther. 19 (2003) 377-384
15. Lambiase A., Bonini S., Aloe L., Rama P., and Bonini S. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch. Ophthalmol. 118 (2000) 1446-1449
16. Lambiase A., Pagani L., Di Fausto V., Sposato V., Coassin M., Bonini S., and Aloe L. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res. 1127 (2007) 45-51
17. Levi-Montalcini R. The nerve growth factor 35 years later. Science 237 (1987) 1154-1162
18. Nishijima K., Ng Y.S., Zhong L., Bradley J., Schubert W., Jo N., Akita J., Samuelsson S.J., Robinson G.S., Adamis A.P., and Shima D.T. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am. J. Pathol. 171 (2007) 53-67
19. Palkovits M., and Brownstein M.J. Maps and Guide to Microdissection of the Rat Brain (1988), Elsevier, New York 223 pp.
20. Saint-Geniez M., Maharaj A.S., Walshe T.E., Tucker B.A., Sekiyama E., Kurihara T., Darland D.C., Young M.J., and D'Amore P.A. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. PLoS ONE 3 (2008) e3554
21. Samii A., Unger J., and Lange W. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats. Neurosci. Lett. 262 (1999) 159-162
22. Schoenwald R.D., Deshpande G.S., Rethwisch D.G., and Barfknecht C.F. Penetration into the anterior chamber via the conjunctival/scleral pathway. J. Ocul. Pharmacol. Ther. 13 (1997) 41-59
23. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24 (2001) 1217-1281
24. Sondell M., Lundborg G., and Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19 (1999) 5731-5740
25. Stoeckel K., Gagnon C., Guroff G., and Thoenen H. Purification of nerve growth factor antibodies by affinity chromatography. J. Neurochem. 26 (1976) 1207-1211
26. Vereczki V., Koves K., Csaki A., Grosz K., Hoffman G.E., and Fiskum G. Distribution of hypothalamic, hippocampal and other limbic peptidergic neuronal cell bodies giving rise to retinopetal fibers: anterograde and retrograde tracing and neuropeptide immunohistochemical studies. Neuroscience 140 (2006) 1089-1100
27. Villoslada P., Hauser S.L., Bartke I., Unger J., Heald N., Rosenberg D., Cheung S.W., Mobley W.C., Fisher S., and Genain C.P. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med. 191 (2000) 1799-1806